Blood Culture Positive Sample Pretreatment Kit - India CDSCO Medical Device Registration

Blood Culture Positive Sample Pretreatment Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000207_f4ab824e31cd8f52bd046e49faefc7dd_21e22cad35bbd96b22620ab09270d35c. This device is marketed under the brand name CLIA. The license holder is Rapid House, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

Blood Culture Positive Sample Pretreatment Kit

UID: IMP/IVD/2023/000207_f4ab824e31cd8f52bd046e49faefc7dd_21e22cad35bbd96b22620ab09270d35c

Brand Name

CLIA

License Holder

Rapid House

Device Class

Class B

Approving Authority

CDSCO

Product Information

This kit is used for cell crushing in positive blood culture medium, separating and enriching of pathogenic bacteria. Combined with the mass spectrometry system, the pure culture of pathogenic microbe can be obtained without subculture again, so as to detect them quickly and accurately

Class B

T3 Assay (T3 Assay )

Brand: CLIA

Rapid House

Class B

Brand: CLIA

Class B